Taipei Exchange - Delayed Quote TWD

Enimmune corporation (6564.TWO)

18.00
+0.35
+(1.98%)
As of 11:35:14 AM GMT+8. Market Open.
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
39,915
39,915
43,494
188,415
109,822
Cost of Revenue
25,689
25,689
66,867
167,573
71,099
Gross Profit
14,226
14,226
-23,373
20,842
38,723
Operating Expense
165,513
165,513
219,934
302,339
97,327
Operating Income
-151,287
-151,287
-243,307
-281,497
-58,604
Net Non Operating Interest Income Expense
375
375
960
974
2,168
Pretax Income
-165,573
-165,573
-237,690
-267,086
-47,246
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-157,546
-157,546
-223,743
-247,963
-47,246
Diluted NI Available to Com Stockholders
-157,546
-157,546
-223,743
-247,963
-47,246
Basic EPS
-2.20
--
-3.40
-3.87
-0.79
Diluted EPS
-2.20
--
-3.40
-3.87
-0.79
Basic Average Shares
71,611.82
--
65,806.77
63,976.45
60,201.99
Diluted Average Shares
71,611.82
--
65,806.77
63,976.45
60,201.99
Total Expenses
191,202
191,202
286,801
469,912
168,426
Net Income from Continuing & Discontinued Operation
-157,546
-157,546
-223,743
-247,963
-47,246
Normalized Income
-157,692
-157,692
-223,575
-243,044
-47,179
Interest Income
2,577
2,577
1,937
1,289
2,393
Interest Expense
2,202
2,202
977
315
225
Net Interest Income
375
375
960
974
2,168
EBIT
-163,371
-163,371
-236,713
-266,771
-47,021
EBITDA
-155,775
-155,775
-228,963
-258,424
-38,398
Reconciled Cost of Revenue
25,689
25,689
66,867
167,573
71,099
Reconciled Depreciation
7,596
7,596
7,750
8,347
8,623
Net Income from Continuing Operation Net Minority Interest
-157,546
-157,546
-223,743
-247,963
-47,246
Total Unusual Items Excluding Goodwill
146
146
-168
-4,919
-67
Total Unusual Items
146
146
-168
-4,919
-67
Normalized EBITDA
-155,921
-155,921
-228,795
-253,505
-38,331
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 9/18/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

6926.TWO Shine-On BioMedical Co.,Ltd.
63.50
-0.78%
 
6580.TWO TaiRx, Inc.
24.05
+0.21%
 
4170.TWO VBI
12.70
-2.31%
 
6814.TWO Lukas Biomedical Inc.
25.10
0.00%
 
6892.TWO Taiwan Bio Therapeutics Co., Ltd
31.45
+0.48%
 
4197.TWO Visgeneer Inc.
10.45
0.00%
 
4732.TWO NatureWise Biotech & Medicals Corporation
19.50
-3.94%
 
6945.TWO AP Biosciences Inc
53.00
-1.12%
 
6549.TWO TaiwanJ Pharmaceuticals Co., Ltd.
7.93
+0.38%
 
6610.TWO TWi Biotechnology, Inc.
10.90
-0.91%